Elicio Therapeutics, Inc. (ELTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $18.56M | +5.4% |
| 2024 | $17.62M | +36.6% |
| 2023 | $12.89M | +109.5% |
| 2022 | $6.16M | -93.1% |
| 2021 | $88.76M | +156.5% |
| 2020 | $34.61M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $18.56M | +5.4% |
| 2024 | $17.62M | +36.6% |
| 2023 | $12.89M | +109.5% |
| 2022 | $6.16M | -93.1% |
| 2021 | $88.76M | +156.5% |
| 2020 | $34.61M | — |